RFQMR technology utilizes a totally different approach compared to conventional cancer treatments. Instead of the very high frequency ionising radiation used in radiotherapy RFQMR uses radio or sub-radio frequency, low power, non-ionising, non thermal electromagnetic waves.
The main concern of the therapy is not the immediate destruction of the cancer cells, but rather with the help of the small amount of energy provided to the cell to stop the DNA’s uncontrolled mitosis, put the cell in a vegetative state and in time through apoptosis mechanism let the body get rid of the cancerous cells in a controlled fashion.
Several clinical studies show that changes in the transmembrane potential of the cells can have dramatic effects on the cell parameters including the ion concentration and more data can be obtained in the Scientific Research Section. RFQMR application helps to increase the transmembrane potential of the cancerous cells from the problematic -20 mV to the healthy -90 mV range. It is believed that the p53 proteins are activated and the uncontrolled mitosis of the cell comes to a halt by the RFQMR application.
No, the treatment is absolutely painless. Patients can even listen to music, see television or read during the treatment.
A phase 1 clinical study has been held at the Institute of Aerospace Medicine in Bangalore India on more than 100 terminal cancer patients. All patients were undergone all possible conventional interventions such as chemo, radiotherapy or surgery prior to RFQMR and yet the disease cannot be controlled and they are supposed to die within a few days to few months due to cancer. Out of such patients :
As all of those patients are supposed to be dead by now, the outcomes of the Cytotron therapy is outstanding. It is believed that in patients who are in a non-terminal situation (in better overall condition, with stronger immune system and was not subject to the toxic conventional therapies with side effects) the efficacy of Cytotron will be even more pronounced.
The Cytotron treatment has been used on more than 300 cancer patients in multiple studies.
Tissue Engineering is the field of altering, modifying, controlled reproduction and controlled regeneration and degeneration of biological tissue. Using Tissue engineering techniques, today it is possible to regenerate dying tissues and organs inside the body, grow new blood vessels, heal wounds or fix an adamant fracture, grow new cartilage or even teach a few lessons to cancerous cells that go into a multiplication spree.
We utilize Cytotron which is the world’s first Rotational Field Quantum Magnetic Resonance (RFQMR) Generator to achieve this. We have the latest second generation RFQMR generator, that looks like a MRI machine, to produce high power multi frequency rotating quantum electromagnetic resonating beams from 288 special RFQMR guns with an aperture of 120 mm, that are precisely focused to the target area of repair. (The first generation RFQMR generators had only 96 guns and an aperture of 40mm.)
In future, RFQMR can prove effective as a non-invasive solution in the treatment of Osteoarthritis, relieving pain and disability due to trauma, temporo-mandibular joint disease, tinnitus, peridontal disease, carpal tunnel syndrome, osteoporosis, tendonitis and convalescence following surgical repair of ligaments, fresh bone fractures in elderly, aseptic necrosis, fibromyalgia, sciatica, post-polio syndrome, migraine, metatarsalgia, acute burns, immune deficiency disorders, drug resistant epilepsy, diabetic neuropathy, herniated disk, problem wound healing, Stimulation of Angiogenic Growth Factor and promoting Coronary and peripheral pro-angiogenesis and retarding the Angiogenic Growth Factor to promote Anti-Angiogenesis in Cancer, degenerating and destroying tumors, by cellular apoptosis (programmed cell death) Another possible application of QMR could be Electroporation. Electroporation involves directly applying QMR pulses of millionths of a second duration and field strength of 100-1500 volts per centimeter to living cells. These pulses cause nanoscopic pores to open up through the cell's membrane. When the pulse stops, the pores close again, trapping the drug or DNA inside the cell. Electroporation can be carried out by applying the QMR pulses either directly to the target tissue to be treated in a living organism, or to cell suspensions and isolated organs. This application of QMR may go a long way, as it will open up the potential for new approaches to medical problems where successful treatment depends on finding ways for the therapeutic molecules to reach the cell interior. This includes - among others - treatments such as cancer chemotherapy, the delivery of DNA for gene therapy and DNA vaccines, the delivery of drugs for treating cardiac and vascular problems as well as the treatment of the eye disease. After more studies are completed, many other potential applications such as the treatment of haemophilia and other genetic defects or the treatment of cardiovascular diseases and the prevention of atherosclerosis can be explored.
Like other tissues, bone and cartilage are constantly being built up and broken down by a variety of metabolic and physical influences. The major stimulus for bone and cartilage formation is a signal generated when these structures are subjected to tension or compression. This explains why bone atrophies in the absence of any significant pressure, such as weightlessness during space travel or immobilization in a cast. The transmission of this signal is also impaired following joint injury due to trauma or diseases such as osteoarthritis. QMR is designed to characterize and reproduce the required signal that initiates these regenerative activities by the induction of a spin in the hydrogen atoms thus creating a streaming potential in the extra cellular matrix (ECM) when bone or cartilage are placed under a load. In other words, when you take a step, putting weight on the joint, the cartilage is compressed, the fluid gets displaced, and it carries with it mobile ions, the sodium ions, leaving behind the negatively charged proteoglycan carboxyl and sulfate ions. This generates an electric potential because you have "unneutralised" negative charges. This is called a streaming potential. RFQMR can recreate this streaming potential and its restorative rewards in joints impaired due to disease or trauma even though they are at rest.
In Degenerative RFQMR, like in the application of destruction of the tumor in a cancer patient, it is thought that the chromosomes, following the messages received as a result of the variations of potential (-70 to -90mV normal, -40 to -60 when infected, -20 to -30 in cancer and 0 when dead) in the cytoplasmic membrane, activate through electromechanical effects (stress responsive), the emission of messages by the genes that regulate cell dynamics for normal cell functions or for the mitochondrial activities for ATP production. It is supposed that the excessive production of ATP is related to an alteration of the glycoproteinic sensors present on the mitochondrion membrane with consequent lowering of the impedance that in turn does not discriminate between the signals in frequency and activates the production of ATP in an almost continual way. The cancer cell would therefore go into mitosis due to the excess of ATP. RFQMR fields are used to act on the mitochondrial membrane, increasing the impedance of the glycoproteinic sensors through the lengthening of the polyglycidic chain. The spin of the RFQMR field is used to interfere with the communications between the genes and the protoplasmic glycoproteinic complexes involved in the promotion of cell mitosis.
By this the impedance of the mitochondrial membrane to the messages coming from the genes increase with the RFQMR treatment and with increase in the malignancy (the highest impedance for undifferentiated tumors). This is related to a greater alteration of the sensors of the undifferentiated tumors and therefore to their greater predisposition to the bond with polyglycidic chains. The undifferentiated cancer cells, because of the high impedance induced on the mitochondrial membrane by the RFQMR treatment, it stops producing ATP and therefore 'possibly' enter into apoptosis. Following the treatment the differentiated cancer cells have an impedance which is still sensitive to some messages coming from the chromosomes promoting the normal production of ATP, so these cells change their state of mitosis; however, they continue to live in a quiescent state (vegetative form of life). The normal cells are not influenced by the RFQMR radiation treatment as the impedance of their mitochondrial sensors is not modified and remain sensitive to messages that arrive from the chromosomes for the activation of the ATP synthesis.
In Degenerative RFQMR, like in the application of destruction of the tumor in a cancer patient, it is thought that the chromosomes, following the messages received as a result of the variations of potential (-70 to -90mV normal, -40 to -60 when infected, -20 to -30 in cancer and 0 when dead) in the cytoplasmic membrane, activate through electromechanical effects (stress responsive), the emission of messages by the genes that regulate cell dynamics for normal cell functions or for the mitochondrial activities for ATP production.
It is supposed that the excessive production of ATP is related to an alteration of the glycoproteinic sensors present on the mitochondrion membrane with consequent lowering of the impedance that in turn does not discriminate between the signals in frequency and activates the production of ATP in an almost continual way. The cancer cell would therefore go into mitosis due to the excess of ATP. RFQMR fields are used to act on the mitochondrial membrane, increasing the impedance of the glycoproteinic sensors through the lengthening of the polyglycidic chain. The spin of the RFQMR field is used to interfere with the communications between the genes and the protoplasmic glycoproteinic complexes involved in the promotion of cell mitosis.
By this the impedance of the mitochondrial membrane to the messages coming from the genes increase with the RFQMR treatment and with increase in the malignancy (the highest impedance for undifferentiated tumors). This is related to a greater alteration of the sensors of the undifferentiated tumors and therefore to their greater predisposition to the bond with polyglycidic chains. The undifferentiated cancer cells, because of the high impedance induced on the mitochondrial membrane by the RFQMR treatment, it stops producing ATP and therefore 'possibly' enter into apoptosis. Following the treatment the differentiated cancer cells have an impedance which is still sensitive to some messages coming from the chromosomes promoting the normal production of ATP, so these cells change their state of mitosis; however, they continue to live in a quiescent state (vegetative form of life). The normal cells are not influenced by the RFQMR radiation treatment as the impedance of their mitochondrial sensors is not modified and remain sensitive to messages that arrive from the chromosomes for the activation of the ATP synthesis.